Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00468234 · ClinicalTrials.gov registry record · NA
Validation of Biomarkers of Exposure and Host Response
A NA study of Cigarette Smoker, sponsored by University of Nebraska.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT00468234 is a NA study of Cigarette Smoker that has completed, run by University of Nebraska. The registered enrollment target is 60 participants, below the 904-participant average among 5 other Cigarette Smoker trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00468234, a NA study of Cigarette Smoker, has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate biomarkers measured in exhaled breath condensate (EBC) to assess clinical strategies of harm reduction. It will take advantage of a recently developed device that permits collection of exhaled breath condensate reproducibly, with minimal subject effort and with no oral contamination. Samples from asymptomatic smokers before and after inducing a change in their smoking habit (cessation or reduction) with the aid of partial nicotine replacement.
Conditions Studied
Interventions
- DRUG nicotine polacrilex
- DRUG nicotine transdermal system
- DRUG nicotine inhaler
Study Locations (1)
Nebraska
- University of Nebraska Medical Center - Omaha
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2005-12 |
| Est. Completion | 2007-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00468234
The ClinicalTrials.gov registry entry for NCT00468234 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 904-participant average among 5 other Cigarette Smoker trials with a reported enrollment target (93% lower). The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cigarette Smoker appearing as the primary indexed condition, and to 3 interventions - of which nicotine polacrilex is the first listed.
NCT00468234 reports 1 study location spanning 1 distinct geographic area - top geographies include Nebraska.
Frequently Asked Questions
What is clinical trial NCT00468234 about?
NCT00468234 is a clinical study titled "Validation of Biomarkers of Exposure and Host Response". This study will evaluate biomarkers measured in exhaled breath condensate (EBC) to assess clinical strategies of harm reduction. It will take advantage of a recently developed device that permits collection of exhaled breath condensate reproducibly, with minimal subject effort and with no oral conta...
What is the current status of trial NCT00468234?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2005-12. Estimated completion is 2007-09.
What conditions does trial NCT00468234 study?
This clinical trial studies the following conditions: Cigarette Smoker.
What interventions are being tested in trial NCT00468234?
The interventions under investigation include: nicotine polacrilex (DRUG), nicotine transdermal system (DRUG), nicotine inhaler (DRUG).
Who is sponsoring clinical trial NCT00468234?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00468234 being conducted?
This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cigarette Smoker
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Beating Lung Cancer in Ohio Protocol in Improving Survival in Patients With Stage IV Non-Small Cell Lung Cancer
RECRUITING · NA
-
Behavioral Activation Therapy and Nicotine Replacement Therapy in Increasing Smoking Cessation
ACTIVE NOT RECRUITING · NA
-
rTMS in Promoting Smoking Cessation and Preventing Relapse in Current Smokers
ACTIVE NOT RECRUITING · NA
-
Varenicline and Combined NRT for Smoking Cessation
ACTIVE NOT RECRUITING · Phase 4
-
18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.